Research Division of Pharmacology, China Pharmaceutical University, Nanjing, China.
Biochem Pharmacol. 2012 Jan 1;83(1):97-105. doi: 10.1016/j.bcp.2011.10.006. Epub 2011 Oct 14.
We tested the hypothesis that aquaporin-4 (AQP4) knockout (KO) mice might exhibit abnormal Ca(2+) modulating proteins resulting from the exacerbation of pro-inflammatory factors in the heart. Downregulation of FKBP12.6, SERCA2a, and CASQ2 and calcium leak in diastole have been recognized as endpoints for assessing cardiac failure and arrhythmias. The AQP4 KO mice and wild-type (WT) mice were randomly divided into 3 groups, such as control, isoproterenol (ISO, β-receptor agonist) injected (1 mg/kg, sc, 5 d), and treated with aminoguanidine (AMG, 100 mg/kg, po, a selective inhibitor of the iNOS) during the last 3d. RT-PCR, western blot and calcium transient measurements were conducted. The results demonstrated that the cardiac weight index was increased in AQP4 KO mice and further increased following treatment with ISO. The expression levels of FKBP12.6, SERCA2a, and CASQ2 were downregulated and diastolic calcium concentrations were elevated in the AQP4 KO mice, indicative of a calcium leak. In the myocardium, expressions of pro-inflammatory biomarkers, including ET(A), pPKCɛ, NADPH oxidase p67(phox) were upregulated and associated with downregulation of Cx43. The aforementioned changes were exacerbated in response to ISO medication and were attenuated by AMG; however, its treatment effectiveness was less in the AQP4 KO mice. We concluded AQP4 KO caused abnormalities of calcium modulating proteins leading to an exacerbation of risk for cardiac arrhythmias and failure. These changes are likely due to an increase in pro-inflammatory factors which are exacerbated by stress. Therefore, AQP4 KO mice are prone to cardiac failure and arrhythmias through exacerbating pro-inflammatory factors in the myocardium.
我们检验了这样一个假设,即水通道蛋白-4(AQP4)敲除(KO)小鼠可能会表现出异常的 Ca(2+)调节蛋白,这是由于心脏中促炎因子的加剧。FKBP12.6、SERCA2a 和 CASQ2 的下调以及舒张期钙渗漏已被认为是评估心力衰竭和心律失常的终点。AQP4 KO 小鼠和野生型(WT)小鼠被随机分为 3 组,如对照组、异丙肾上腺素(ISO,β-受体激动剂)注射(1mg/kg,sc,5d)和最后 3d 用氨基胍(AMG,100mg/kg,po,iNOS 的选择性抑制剂)治疗。进行 RT-PCR、western blot 和钙瞬变测量。结果表明,AQP4 KO 小鼠的心脏重量指数增加,在用 ISO 处理后进一步增加。FKBP12.6、SERCA2a 和 CASQ2 的表达水平下调,AQP4 KO 小鼠舒张期钙浓度升高,提示钙渗漏。在心肌中,促炎生物标志物的表达,包括 ET(A)、pPKCɛ、NADPH 氧化酶 p67(phox)上调,并与 Cx43 的下调相关。上述变化在 ISO 药物治疗后加剧,并被 AMG 减弱;然而,在 AQP4 KO 小鼠中,其治疗效果较差。我们得出结论,AQP4 KO 导致钙调节蛋白异常,导致心律失常和心力衰竭风险加剧。这些变化可能是由于促炎因子的增加,而应激会加剧这种增加。因此,AQP4 KO 小鼠通过加剧心肌中的促炎因子容易发生心力衰竭和心律失常。